Table 2. Multivariate analysis for prognosis of gastric cancer patients.
Clinical Characteristics | Group | Survival time | ||
---|---|---|---|---|
HR | 95%CI | P | ||
Expression of miRNA-451 | High/Low | 2.215 | 1.698∼4.241 | 0.0001 |
Gender | Male/Female | 1.116 | 0.901∼1.502 | 0.4582 |
Age | ≤50/>50 | 1.058 | 0.911∼1.184 | 0.6247 |
Clinical stage | I,II/III,IV | 1.796 | 1.178∼2.462 | 0.0016 |
Diameter | ≤4cm/>4cm | 1.863 | 1.241∼3.027 | 0.3475 |
Lymph node metastasis | No/Yes | 1.802 | 1.324∼2.187 | 0.0024 |
Abbreviation: HR, Hazard Ratio; CI, Confidence Interval; CI, Confidence Interval.